Skip to main content

Table 3 PD-1 and PD-L1 expression levels in uterine cancer (450 specimens) [67]

From: Immunotherapy in endometrial cancer - an evolving therapeutic paradigm

Histology

PD-1

PD-L1

 

% Expression based on IHC staining*

Endometrioid

77.9

39.7

Serous Carcinoma

68.2

10.2

Carcinosarcoma

80.0

22.2

Leiomyosarcoma

46.9

36.0

Stromal Sarcoma

64.3

64.3

Clear Cell Carcinoma

69.2

23.1

  1. * IHC antibody = Spring Bioscience (Rabbit anti-Human IgG)